Among the breast cancer subtypes, triple-negative breast cancer (TNBC) is characterized by the absence of estrogen and progesterone receptors and lack of excess of human epidermal growth factor receptor 2 (HER2) expression. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.